Nucleic acid-binding polymers as anti-inflammatory agents: Reducing the danger of nuclear attack

Expert Review of Clinical Immunology

Volumn 8, Issue 1, 2012, Pages 1-3

  Pisetsky, David S ^a,c   Lee, Jaewoo ^b   Leong, Kam W ^c   Sullenger, Bruce A ^b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

DNA; innate immunity; polymers; RNA; Toll like receptors

Indexed keywords

ANTIINFLAMMATORY AGENT; NUCLEIC ACID BINDING POLYMER; POLYMER; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CELL NUCLEUS; DRUG MECHANISM; DRUG RESEARCH; HUMAN; INFLAMMATION; NONHUMAN; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; NUCLEIC ACIDS; POLYMERS;

EID: 83455217640     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.11.82     Document Type: Review

References (20)

1. Lee J, Sohn JW, Zhang Y, Leong KW, Pisetsky D, Sullenger BA. Nucleic acid-binding polymers as anti-inflammatory agents. Proc. Natl Acad. Sci. USA 108 (34), 14055-14060 (2011).
2. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279-288 (2008).
3. Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826-837 (2010).
4. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
5. Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 28(10), 429-436 (2007).
6. Ardoin SP, Pisetsky DS. Developments in the scientific understanding of lupus. Arthritis Res. Ther. 10(5), 218 (2008).
7. Kawasaki T, Kawai T, Akira S. Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol. Rev. 243, 61-73 (2011).
8. Takaoka A, Wang Z, Choi MK et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501-506 (2007).
9. Vallin H, Perers A, Alm GV, Rönnblom L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-a inducer in systemic lupus erythematosus. J. Immunol. 163, 6306-6313 (1999).
10. Boulé MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199(12), 1631-1640 (2004).
11. Lande R, Gregorio J, Facchinetti V et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-571 (2007).
12. Tian J, Avalos AM, Mao SY et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8(5), 487-497 (2007).
13. Urbonaviciute V, Fürnrohr BG, Meister S et al. Induction of inflammatory and immune responses by HMGB1- nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 205(13), 3007-3018 (2008).
14. Hreggvidsdottir HS, Ostberg T, Wähämaa H et al. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol. 86(3), 655-662 (2009).
15. Pisetsky D. Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexes. Swiss Med Wkly 141, 13256-13263 (2011).
16. Prinz M, Garbe F, Schmidt H et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116(2), 456-464 (2006).
17. Franklin BS, Ishizaka ST, Lamphier M et al. Therapeutical targeting of nucleic acid-sensing toll-like receptors prevents experimental cerebral malaria. Proc. Natl Acad. Sci. USA 108(9), 3689-3694 (2011).
18. Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat. Rev. 4, 581-593 (2005).
19. Bartlett DW, Davis ME. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bioconjugate Chem. 18, 456-468 (2007).
20. Oney S, Lam RTS, Bompiani KM et al. Development of universal antidotes to control aptamer activity. Nat. Med. 15(10), 1224-1229 (2009).